Indication

Squamous Cell Carcinoma of the Paranasal Sinus

1 clinical trial

2 products

Clinical trial

A Phase I/II Study of Concurrent Cetuximab and Nivolumab in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

Status: Active (not recruiting), Estimated PCD: 2021-09-04

Product

Product